Literature DB >> 29911457

Transient elevation of anti-transglutaminase and anti-endomysium antibodies in Giardia infection.

Kurt Hanevik1,2, Elisabeth Wik3,4, Nina Langeland1,2, Trygve Hausken5.   

Abstract

Markers of celiac disease (CeD) may be elevated in various conditions of intestinal inflammation or autoimmune disease. Recent reports argue that intestinal infection may induce development of CeD in susceptible individuals. Serum anti-tissue transglutaminase (tTG) and anti-endomysium antibodies (EMA) have been proposed in previous reports to be helpful in differentiating between giardiasis and CeD. In this report, we describe eight cases with elevated CeD serological markers and pathological duodenal histology during, or shortly after, Giardia infection. We present follow-up clinical and serological findings to determine which of these that were diagnosed with CeD. Serum levels of tTGand EMA did not discriminate well between patients where CeD was excluded, and those who were later diagnosed with CeD. The value of these serological CeD markers is discussed in relation to CeD diagnosis in cases with chronic or recent giardiasis.

Entities:  

Keywords:  EMA; Giardia; celiac disease; duodenal inflammation; tTG

Mesh:

Substances:

Year:  2018        PMID: 29911457     DOI: 10.1080/00365521.2018.1481522

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

Review 1.  Celiac Disease Revisited.

Authors:  João Calado; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2021-03-17

Review 2.  Contribution of Infectious Agents to the Development of Celiac Disease.

Authors:  Daniel Sánchez; Iva Hoffmanová; Adéla Szczepanková; Věra Hábová; Helena Tlaskalová-Hogenová
Journal:  Microorganisms       Date:  2021-03-06

Review 3.  Celiac disease: histology-differential diagnosis-complications. A practical approach.

Authors:  Vincenzo Villanacci; Alessandro Vanoli; Giuseppe Leoncini; Giovanni Arpa; Tiziana Salviato; Luca Reggiani Bonetti; Carla Baronchelli; Luca Saragoni; Paola Parente
Journal:  Pathologica       Date:  2020-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.